Amneal Pharmaceuticals (AMRX) Receivables (2017 - 2026)
Amneal Pharmaceuticals' Receivables was $1.03 billion in Q2 2026, up 24.2% from $825.56 million a year earlier and up 19.6% from the prior quarter.
Amneal Pharmaceuticals (AMRX) Receivables (2017 - 2026) Analysis & Trends
At the end of FY2025, Receivables at Amneal Pharmaceuticals came in at $900.91 million, up 15.4% from FY2024.
- Receivables shows a five-year compound annual growth rate of 6.6% (FY2020 to FY2025).
- In earlier years, Receivables was $780.68 million in FY2024 (+25.0%), $624.62 million in FY2023 (-19.4%), $774.92 million in FY2022 (+15.3%) and $672.35 million in FY2021 (+2.5%).
- The Q2 2026 figure marks the highest quarterly Receivables in data going back to Q4 2017.
- Compared with a year earlier, Receivables has increased for ten straight quarters, with growth averaging 15.0% over the last eight quarters.
- The best year-over-year quarter for Receivables over five years was Q4 2024 (growth of 25.0%); the worst was Q4 2023 (a decline of 19.4%).
- Per Business Quant data, AMRX's Receivables in the three quarters before Q2 2026 was $857.53 million (Q1 2026), $900.91 million (Q4 2025) and $901.33 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,160.09 Bn | 1,128.68 Bn | 19.71 Bn | 23.48 Bn |
| 2 | Johnson & Johnson | 624.76 Bn | 543.28 Bn | 17.26 Bn | 19.05 Bn |
| 3 | AbbVie | 511.79 Bn | 484.90 Bn | 12.70 Bn | 13.82 Bn |
| 4 | Merck | 366.25 Bn | 320.63 Bn | 12.21 Bn | 12.56 Bn |
| 5 | Novartis Ag | 297.28 Bn | 261.27 Bn | 11.24 Bn | 9.64 Bn |
| 6 | Astrazeneca | 261.26 Bn | 234.95 Bn | 12.86 Bn | 15.68 Bn |
| 7 | Amgen | 234.84 Bn | 190.23 Bn | 7.24 Bn | 10.23 Bn |
| 8 | Gilead Sciences | 193.93 Bn | 168.13 Bn | 6.22 Bn | 5.06 Bn |
| 9 | Pfizer | 171.68 Bn | 118.33 Bn | 10.94 Bn | 12.49 Bn |
| 10 | Amneal Pharmaceuticals | 6.24 Bn | 5.43 Bn | 334.51 Mn | 1.03 Bn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.03 Bn |
| Mar 31, 2026 | 857.53 Mn |
| Dec 31, 2025 | 900.91 Mn |
| Sep 30, 2025 | 901.33 Mn |
| Jun 30, 2025 | 825.56 Mn |
| Mar 31, 2025 | 775.23 Mn |
| Dec 31, 2024 | 780.68 Mn |
| Sep 30, 2024 | 764.49 Mn |
| Jun 30, 2024 | 786.52 Mn |
| Mar 31, 2024 | 681.76 Mn |
| Dec 31, 2023 | 624.62 Mn |
| Sep 30, 2023 | 707.66 Mn |
| Jun 30, 2023 | 689.36 Mn |
| Mar 31, 2023 | 559.78 Mn |
| Dec 31, 2022 | 774.92 Mn |
| Sep 30, 2022 | 638.10 Mn |
| Jun 30, 2022 | 706.60 Mn |
| Mar 31, 2022 | 585.52 Mn |
| Dec 31, 2021 | 662.68 Mn |
| Sep 30, 2021 | 673.25 Mn |
Amneal Pharmaceuticals Receivables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables&ticker=AMRX&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables", "ticker": "AMRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=receivables&ticker=AMRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();